Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy. Issue 2 (February 2017)
- Record Type:
- Journal Article
- Title:
- Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy. Issue 2 (February 2017)
- Main Title:
- Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy
- Authors:
- Haghikia, Aiden
Dendrou, Calliope A
Schneider, Ruth
Grüter, Thomas
Postert, Thomas
Matzke, Mike
Stephanik, Heike
Fugger, Lars
Gold, Ralf - Abstract:
- Is Part Of:
- Lancet neurology. Volume 16:Issue 2(2017:Feb.)
- Journal:
- Lancet neurology
- Issue:
- Volume 16:Issue 2(2017:Feb.)
- Issue Display:
- Volume 16, Issue 2 (2017)
- Year:
- 2017
- Volume:
- 16
- Issue:
- 2
- Issue Sort Value:
- 2017-0016-0002-0000
- Page Start:
- 104
- Page End:
- 106
- Publication Date:
- 2017-02
- Subjects:
- Neurology -- Periodicals
Neurology -- Periodicals
Nervous System Diseases -- Periodicals
Neurologie -- Périodiques
Neurology
Electronic journals
Periodicals
616.805 - Journal URLs:
- http://www.thelancet.com/journals/laneur ↗
http://www.sciencedirect.com/science/journal/14744422 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S1474-4422(16)30382-9 ↗
- Languages:
- English
- ISSNs:
- 1474-4422
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.084000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2600.xml